Semorinemab Pharmacokinetics and The Effect on Plasma Total Tau Pharmacodynamics in Clinical Studies.

Saved in:
Bibliographic Details
Title: Semorinemab Pharmacokinetics and The Effect on Plasma Total Tau Pharmacodynamics in Clinical Studies.
Authors: Ramakrishnan V; Vidya Ramakrishnan, Genentech Inc., 1 DNA Way, South San Francisco, CA 94080, Tel: +1 (650) 225-6154, ramakrishnan.vidya@gene.com., Bender B, Langenhorst J, Magnusson MO, Dolton M, Shim J, Fuji RN, Monteiro C, Teng E, Kassir N, Jin J
Source: The journal of prevention of Alzheimer's disease [J Prev Alzheimers Dis] 2024; Vol. 11 (5), pp. 1241-1250.
Publication Type: Journal Article; Clinical Trial, Phase I
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101638820 Publication Model: Print Cited Medium: Internet ISSN: 2426-0266 (Electronic) Linking ISSN: 22745807 NLM ISO Abbreviation: J Prev Alzheimers Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2426-0266
DOI:10.14283/jpad.2024.146